Navrogen
Luigi Grasso is an experienced Chief Scientific Officer with a background in Oncology, Cancer Biology, and Clinical Pathology. Luigi has held significant roles in companies such as Navrogen, Morphotek, Inc., and Magainin Pharmaceuticals Inc., where Luigi has been instrumental in strategic planning, managing operations, and developing pipeline technologies. Luigi has a strong track record of successful collaborations and partnerships in the biotechnology industry.
This person is not in any teams
Navrogen
Navrogen Inc. is a biopharmaceutical company that focuses on the targeted treatment of cancer. The company works on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.